Zobrazeno 1 - 10
of 614
pro vyhledávání: '"post-transplantation cyclophosphamide"'
Autor:
Alexis A. Franco, Viviana Lotero, Pamela Rodríguez, Estefania Beltran, Eliana Manzi, Angela Devia-Zapata, Diego Medina-Valencia
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss 4, Pp 420-427 (2024)
Introduction: Acute myeloid leukemia is a challenging disease, due to a poor prognosis in developing countries. Herein, we aim to describe the clinical characteristics and outcomes after chemotherapy and transplantation. Methods: A retrospective anal
Externí odkaz:
https://doaj.org/article/38388c1a438440edb496083bb25280c9
Autor:
Moisés Manuel Gallardo-Pérez, César Homero Gutiérrez-Aguirre, Juan Carlos Olivares-Gazca, Guillermo José Ruiz-Argüelles
Publikováno v:
Hematology, Vol 29, Iss 1 (2024)
Haploidentical hematopoietic can be conducted on an outpatient basis but the two main reasons to accept into the hospital a patient in this setting are complications of the hematological toxicity and/or the cytokine-release syndrome. With the aim of
Externí odkaz:
https://doaj.org/article/d7ab91357a1948cc9ac543b4f56bc62f
Publikováno v:
陆军军医大学学报, Vol 46, Iss 4, Pp 326-330 (2024)
Objective To retrospectively analyze the efficacy and safety of low-dose antithymocyte globulin (ATG) combined with low-dose post transplantation cyclophosphamide (PTCY) in prevention of graft versus host disease (GVHD) after haploidentical transplan
Externí odkaz:
https://doaj.org/article/ece00742745343289859db1053acae81
Autor:
Franco, Alexis A. a, b, Lotero, Viviana b, c, Rodríguez, Pamela b, c, Beltran, Estefania d, Manzi, Eliana b, d, Devia-Zapata, Angela d, Medina-Valencia, Diego a, b, ⁎
Publikováno v:
In Hematology, Transfusion and Cell Therapy October-December 2024 46(4):420-427
Autor:
Morsink, Linde M. 1, 3, ⁎, Hazenberg, Carin L.E. 1, 3, Choi, Goda 1, 3, de Groot, Marco R. 1, 3, Biswana, Anouschka 1, 3, Bellido, Mar 1, 3, Kooistra, Hilde A.M. 1, 3, Bungener, Laura B. 2, 3, Meijer, Kees 2, 3, Mulder, Andre B. 2, 3, Huls, Gerwin 1, 3
Publikováno v:
In Transplantation and Cellular Therapy August 2024 30(8):794-807
Autor:
Fu, Andie 1, #, Peng, Yizhou 1, #, Cheng, Ping 2, Wu, Jiaying 1, Zhu, Xiaojian 1, Yang, Yang 1, Huang, Lifang 1, Wang, Na 1, Wang, Jue 1, Xu, Jinhuan 1, Wan, Yuling 1, Cao, Yang 1, Wei, Jia 1, Xiao, Yi 1, Meng, Fankai 1, ⁎, Cheng, Hui 2, Zhang, Yicheng 1, Zhang, Donghua 1
Publikováno v:
In Transplantation and Cellular Therapy May 2024 30(5):500-509
Autor:
Gong, Susu 1, Tian, Xin 2, Yang, Rui 3, Yang, Liangchun 4, Wang, Zhiming 5, Yang, Kaitai 1, Chen, Keke 2, He, Xianglin 2, Deng, Wenjun 4, Yang, Xiaoyang 5, Lei, Meiqing 5, Fu, Bin 1, ⁎
Publikováno v:
In Transplantation and Cellular Therapy August 2024
Autor:
Arnon Nagler, Myriam Labopin, Didier Blaise, Anna Maria Raiola, Lucia Lopez Corral, Stefania Bramanti, Simona Sica, Mi Kwon, Yener Koc, Jiri Pavlu, Alexander Kulagin, Alessandro Busca, Arancha Bermúdez Rodríguez, Péter Reményi, Christoph Schmid, Eolia Brissot, Jaime Sanz, Ali Bazarbachi, Sebastian Giebel, Fabio Ciceri, Mohamad Mohty
Publikováno v:
Journal of Hematology & Oncology, Vol 16, Iss 1, Pp 1-15 (2023)
Abstract We compared outcomes of adult patients with secondary acute myeloid leukemia (sAML) versus de novo AML after non-T-depleted haploidentical stem cell transplant (HaploSCT) with post-transplant cyclophosphamide (PTCy). Seventeen hundred and el
Externí odkaz:
https://doaj.org/article/6fbb6abdac6d4d3d94c3604d2e4a2b70
Autor:
Li, Yun a, 1, Wang, Na a, 1, Zhang, Xiaoying a, Cao, Yang a, Zhang, Lingfeng a, Liu, Aiguo b, Zhang, Yicheng a, c, ⁎
Publikováno v:
In Blood Reviews November 2023 62
Autor:
Juan Carlos Olivares-Gazca, María de Lourdes Pastelín-Martínez, Merittzel Abigail Montes-Robles, Moisés Manuel Gallardo-Pérez, Edgar J. Hernández-Flores, Max Robles-Nasta, Daniela Sánchez-Bonilla, Guillermo J. Ruiz-Delgado, Guillermo J. Ruiz-Argüelles
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTObjectives: Allogeneic hematopoietic stem cell transplantation (HSCT) remains the most important curative modality for several hematologic malignancies, but an HLA-matched sibling or unrelated donor is not always available, particularly for e
Externí odkaz:
https://doaj.org/article/086f44f5a5744719b3af36c70ede2a5b